Press releases

All Regulatory posts
22 February 2023 Regulatory Scandion Oncology – Q4 & year-end report 2022 Download Presentation Webcast Workbook
19 January 2023 Regulatory Scandion Oncology A/S: Scandion Oncology receives favorable opinion from the European Patent Office on Composition of Matter Patent-application for lead compound SCO-101 Download Presentation Webcast Workbook
1 December 2022 Regulatory Scandion Oncology appoints Francois Martelet, M.D., as new Chief Executive Officer Download Presentation Webcast Workbook
16 November 2022 Regulatory Scandion Oncology – Interim Report Q3 2022 Download Presentation Webcast Workbook
28 October 2022 Regulatory Scandion Oncology Announces Results of Extraordinary General Meeting Download Presentation Webcast Workbook
13 October 2022 Regulatory Scandion Oncology – Notice convening an Extraordinary General Meeting Download Presentation Webcast Workbook
30 September 2022 Regulatory Scandion Oncology announce topline results from part 2 of the CORIST phase II trial Download Presentation Webcast Workbook
31 August 2022 Regulatory Bo Rode Hansen is leaving the position as President and CEO of Scandion Oncology Download Presentation Webcast Workbook
30 August 2022 Regulatory Scandion Oncology announce change to its Executive Management Download Presentation Webcast Workbook
25 August 2022 Regulatory Scandion Oncology – Interim Report Q2 2022 Download Presentation Webcast Workbook
17 August 2022 Regulatory Scandion Oncology extends PANTAX trial due to better-than-expected tolerability of SCO-101 Download Presentation Webcast Workbook
1 July 2022 Regulatory Scandion Oncology announces preliminary outcome of its rights issue Download Presentation Webcast Workbook
1 June 2022 Regulatory Scandion Oncology resolves on a Rights Issue of approximately SEK 93.7 million Download Presentation Webcast Workbook
19 May 2022 Regulatory Scandion Oncology – Interim Report Q1 2022 Download Presentation Webcast Workbook
27 April 2022 Regulatory Scandion Oncology Announces Results of Annual General Meeting and Constitution of the Board of Directors Download Presentation Webcast Workbook
12 April 2022 Regulatory Scandion Oncology – Notice convening of Annual General Meeting Download Presentation Webcast Workbook
24 March 2022 Regulatory Scandion Oncology – Annual Report 2021 Download Presentation Webcast Workbook
17 February 2022 Regulatory Scandion Oncology announces its results for the fourth quarter and year-end 2021 Download Presentation Webcast Workbook
1 December 2021 Regulatory Scandion Oncology announce minutes of Extraordinary General Meeting Download Presentation Webcast Workbook
18 November 2021 Regulatory Scandion Oncology A/S announces its results for the third quarter of 2021 Download Presentation Webcast Workbook
17 November 2021 Regulatory Scandion Oncology announce notice convening an Extraordinary General Meeting Download Presentation Webcast Workbook
12 November 2021 Regulatory Scandion Oncology announce cancellation of extraordinary general meeting Download Presentation Webcast Workbook
8 November 2021 Regulatory PANTAX study read-out postponed Download Presentation Webcast Workbook
2 November 2021 Regulatory Scandion Oncology A/S: Notice convening an Extraordinary General Meeting Download Presentation Webcast Workbook
4 October 2021 Regulatory Scandion Oncology A/S: Cancellation of extraordinary general meeting Download Presentation Webcast Workbook
21 September 2021 Regulatory Scandion Oncology A/S: Notice convening an Extraordinary General Meeting Download Presentation Webcast Workbook
8 September 2021 Regulatory Scandion Oncology provides a clear path to market for SCO-101 at today’s Capital Markets Day Download Presentation Webcast Workbook
7 September 2021 Regulatory Scandion Oncology strengthens its Clinical Advisory Board with three new members Download Presentation Webcast Workbook
6 September 2021 Regulatory Scandion Oncology receives approval for initiating the CORIST part 2 trial Download Presentation Webcast Workbook
2 September 2021 Regulatory Positive Results from the Scandion Oncology A/S and Alligator Bioscience AB Collaboration Further Supports Efficacy of SCO-101 in Combination Therapy Download Presentation Webcast Workbook
25 August 2021 Regulatory First US patent granted to Scandion Oncology on combination treatment with its candidate drug SCO-101 Download Presentation Webcast Workbook
19 August 2021 Regulatory Scandion Oncology A/S announces its results for the first half year of 2021 Download Presentation Webcast Workbook
24 June 2021 Regulatory Scandion Oncology reports positive interim results from the CORIST Phase II study Download Presentation Webcast Workbook
26 May 2021 Regulatory Scandion Oncology A/S: Minutes of the Annual General Meeting 2021 Download Presentation Webcast Workbook
20 May 2021 Regulatory Q1 2021 Report: Scandion Oncology is evolving Download Presentation Webcast Workbook
10 May 2021 Regulatory Scandion Oncology A/S: Notice convening the Annual General Meeting 2021 Download Presentation Webcast Workbook
29 April 2021 Regulatory Annual Report 2020: Scandion Oncology is setting the pace for the future Download Presentation Webcast Workbook
18 February 2021 Regulatory Year-end Report 2020: Scandion Oncology is poised for the future Download Presentation Webcast Workbook
28 January 2021 Regulatory Scandion Oncology adjusts the PANTAX pancreatic cancer study Download Presentation Webcast Workbook
23 January 2021 Regulatory Scandion Oncology has finalized the first 12 patients in the CORIST study Download Presentation Webcast Workbook
15 December 2020 Regulatory SCANDION ONCOLOGY ANNOUNCES OUTCOME IN THE RIGHTS ISSUE Download Presentation Webcast Workbook
19 November 2020 Regulatory Interim Report 1 January 2020 – 30 September 2020 Download Presentation Webcast Workbook
16 November 2020 Regulatory The Board of Directors of Scandion Oncology has resolved on a fully guaranteed rights issue of approximately SEK 236 million Download Presentation Webcast Workbook
13 November 2020 Regulatory Correction: Scandion Oncology – Minutes of extraordinary general meeting Download Presentation Webcast Workbook
13 November 2020 Regulatory Scandion Oncology – Minutes of extraordinary general meeting Download Presentation Webcast Workbook
28 October 2020 Regulatory Scandion Oncology: Notice to convene Extraordinary General Meeting in Scandion Oncology A/S Download Presentation Webcast Workbook
28 October 2020 Regulatory Scandion Oncology A/S initiates its second clinical study with SCO-101 Download Presentation Webcast Workbook
7 October 2020 Regulatory Scandion Oncology announces modified timelines for clinical studies Download Presentation Webcast Workbook
6 October 2020 Regulatory Scandion Oncology receives approximately MSEK 12.3 through successful warrant exercise Download Presentation Webcast Workbook
3 October 2020 Regulatory Scandion Oncology announces that it has been selected for the final round of MATWIN presentations Download Presentation Webcast Workbook
2 October 2020 Regulatory Communique from the Extraordinary General Meeting of Scandion Oncology A/S Download Presentation Webcast Workbook
28 September 2020 Regulatory Scandion Oncology receives final approval from the Danish Medicines Agency and Ethical Committee for start of a clinical trial in patients with pancreatic cancer Download Presentation Webcast Workbook
16 September 2020 Regulatory Notice to Extraordinary General Meeting in Scandion Oncology A/S Download Presentation Webcast Workbook
16 September 2020 Regulatory Scandion Oncology strengthens executive leadership appointing Bo Rode Hansen as CEO and Nils Brünner as new CSO Download Presentation Webcast Workbook
20 August 2020 Regulatory Scandion Oncology announces results from the next evaluable chemo-resistant colorectal cancer patient treated with SCO-101 and chemotherapy Download Presentation Webcast Workbook
20 August 2020 Regulatory Half-Year Report 1 January 2020 – 30 June 2020 Download Presentation Webcast Workbook
1 August 2020 Regulatory Scandion Oncology announces that one of its founders, Saniona, has reduced its shareholding to below 10% of the total share amount Download Presentation Webcast Workbook
31 July 2020 Regulatory Scandion Oncology drug SCO-101 potentiates the effect of chemotherapy in the first cohort of patients with chemo-resistant metastatic colorectal cancer Download Presentation Webcast Workbook
11 July 2020 Regulatory Scandion Oncology announces that the results of the 4 SCO-101 clinical phase I trials have been published in the journal “Basic & Clinical Pharmacology & Toxocology”. Download Presentation Webcast Workbook
3 July 2020 Regulatory Scandion Oncology announces that its Chairman of the Board has bought 6000 shares in Scandion Oncology Download Presentation Webcast Workbook
30 June 2020 Regulatory Scandion Oncology co-founders extend lock-up period Download Presentation Webcast Workbook
22 June 2020 Regulatory Scandion Oncology announces that one of its founders, Saniona, has reduced its shareholding to below 15% of the total share amount Download Presentation Webcast Workbook
16 June 2020 Regulatory Scandion Oncology has received a Eurostars grant of 800,000 EUR, shared with Erasmus Medical Centre, Rotterdam and 2cureX AB, for evaluating SCO-101 against antiestrogen resistance in breast cancer Download Presentation Webcast Workbook
9 June 2020 Regulatory Scandion Oncology announces that the Clinical Trial Application for a pancreatic cancer study with chemotherapy and SCO-101 has been submitted to the Danish Medicines Agency and the Ethical Committee. Download Presentation Webcast Workbook
4 June 2020 Regulatory Alligator Bioscience and Scandion Oncology sign preclinical agreement to explore combination therapies for chemotherapy and immuno-oncology Download Presentation Webcast Workbook
27 May 2020 Regulatory Scandion Oncology announces that the first patient has received treatment with SCO-101 in combination with FOLFIRI. Download Presentation Webcast Workbook
21 May 2020 Regulatory Interim report 1 January – 31 March 2020 Download Presentation Webcast Workbook
15 May 2020 Regulatory Scandion Oncology’s drug SOM-001 demonstrates antibiotic activity in a mouse model infected with MRSA bacteria Download Presentation Webcast Workbook
11 May 2020 Regulatory Notice to Annual General Meeting in Scandion Oncology A/S Download Presentation Webcast Workbook
30 April 2020 Regulatory Scandion Oncology A/S Annual Report 2019 published Download Presentation Webcast Workbook
25 March 2020 Regulatory SCO-101 works in synergy with the chemotherapy drug docetaxel in drug resistant cancer cells Download Presentation Webcast Workbook
23 March 2020 Regulatory Clinical development plans for SCO-101 Download Presentation Webcast Workbook
20 March 2020 Regulatory Short delay of the antibiotic resistance data Download Presentation Webcast Workbook
9 March 2020 Regulatory Short delay in the clinical phase II study Download Presentation Webcast Workbook
20 February 2020 Regulatory Year-end Report 1 January – 31 December 2019 Download Presentation Webcast Workbook
19 February 2020 Regulatory Scandion Oncology receives DKK 5 million in soft money from Innovation Fund Denmark Download Presentation Webcast Workbook
3 February 2020 Regulatory Correction of dates for public information on Estimated Primary Completion and Primary Study Completion for a Clinical Phase II study Download Presentation Webcast Workbook
23 December 2019 Regulatory Scandion Oncology obtains approval from the Ethics Committee on Clinical Application for SCO-101 in patients with drug-resistant metastatic colorectal cancer Download Presentation Webcast Workbook
16 December 2019 Regulatory Anti-bacterial treatment: Novel analogues with more than tenfold higher potency identified and technical issues with the in vivo experiments Download Presentation Webcast Workbook
29 November 2019 Regulatory Chairman and Vice-Chairman of the Board in Scandion Oncology A/S buy Company shares Download Presentation Webcast Workbook
29 November 2019 Regulatory Scandion Oncology receives final approval from the Danish Medicines Agency for start of clinical Phase II trial in patients with drug resistant metastatic colorectal cancer Download Presentation Webcast Workbook
21 November 2019 Regulatory Interim Report 1 January 2019 – 30 September 2019 Download Presentation Webcast Workbook
14 October 2019 Regulatory Scandion Oncology A/S receives EU-patent for SCO-101 Download Presentation Webcast Workbook
1 October 2019 Regulatory Scandion Oncology applies for start of clinical Phase II trial in patients with metastatic colorectal cancer Download Presentation Webcast Workbook
1 October 2019 Regulatory In vivo animal data report on antibiotic resistance extended until mid-Q4 2019 Download Presentation Webcast Workbook
1 October 2019 Regulatory Peter Høngaard new Chairman of the Board in Scandion Oncology Download Presentation Webcast Workbook
22 August 2019 Regulatory Half-Year Report 1 January 2019 – 30 June 2019 Download Presentation Webcast Workbook
12 July 2019 Regulatory Significantly oversubscribed rights issue in Scandion Oncology Download Presentation Webcast Workbook
17 June 2019 Regulatory Scandion Oncology A/S publishes prospectus in connection with rights issue Download Presentation Webcast Workbook
11 June 2019 Regulatory Communique from the Extraordinary General Meeting in Scandion Oncology A/S Download Presentation Webcast Workbook
31 May 2019 Regulatory Communique from the Annual General Meeting of Scandion Oncology A/S Download Presentation Webcast Workbook
27 May 2019 Regulatory Notice of Extraordinary General Meeting in Scandion Oncology A/S Download Presentation Webcast Workbook
27 May 2019 Regulatory The board of Scandion Oncology proposes a rights issue to increase the commercial potential for its drug candidates and to expand its drug pipeline Download Presentation Webcast Workbook
27 May 2019 Regulatory Interim report 1 January – 31 March 2019 Download Presentation Webcast Workbook
21 May 2019 Regulatory SCANDION ONCOLOGY A/S obtains “Intention to Grant” notice for SCO-101 from the European Patent Office (EPO) Download Presentation Webcast Workbook
14 May 2019 Regulatory Notice to Annual General Meeting in Scandion Oncology A/S Download Presentation Webcast Workbook
3 May 2019 Regulatory Scandion Oncology A/S Annual Report 2018 published Download Presentation Webcast Workbook
16 April 2019 Regulatory Scandion Oncology signs collaboration agreement with University of Copenhagen regarding co-development of a class of drug candidates that reverts anti-cancer drug resistance Download Presentation Webcast Workbook
8 April 2019 Regulatory Scandion Oncology obtains EU Funding for SCO-101 in drug resistant breast cancer patients Download Presentation Webcast Workbook
26 March 2019 Regulatory Scandion Oncology A/S reports successful meeting with Danish Medicines Agency regarding clinical development of SCO-101 Download Presentation Webcast Workbook
21 February 2019 Regulatory Year-end Report 1 January – 31 December 2018 Download Presentation Webcast Workbook
22 November 2018 Regulatory Interim Report Q3 2018 Download Presentation Webcast Workbook